SEC/CFTC Harmonization Panel Urges
Continued Use of Derivatives
At
the recent meeting on the harmonization of regulation between the SEC and CFTC,
former CFTC Chair Sharon Brown-Hruska said that she does not understand the
panic-stricken reaction to credit default swaps (“CDSs”). Except for CDSs
for mortgage-backed securities, the CDS market has performed well, she said.
Brown-Hruska was one several experts that discussed harmonization as it relates
to investment funds.
Brown-Hruska said that proposals for a wholesale restructuring of
the derivatives market go well beyond what is needed. Lawmakers should look at
regulation of over-the-counter (“OTC”) derivatives in the context of
systemic risk, and should consider regulating more forcefully in this area, she
said. However, she is concerned about ongoing discussions regarding a ban on
CDSs. They are vital to the liquidity of the markets, she said.
Former Congressman Richard Baker, who is now the president and CEO
of the Managed Funds Association (“MFA”), said that CDSs have been used
inappropriately at times, but are not a bad product. They serve a very useful
business purpose, he said.
On the topic of regulatory harmonization, Baker said that the MFA
favors simplification of the registration requirements for, and regulation of,
market participants whose activities in the OTC derivates markets are
systemically significant. The association also would like to see consistent
regulation of OTC derivative products within asset classes, and the creation of
a central trade repository to streamline the reporting of trades and other
transaction information as part of an OTC derivatives reporting system.
Michael Connelly, vice chairman of the board of directors of the
Association of Financial Professionals (“AFP”) and treasurer of Tiffany
& Co., favors the enhancement of derivatives regulation, but fears that it
will be too focused on the speculative uses of derivatives. He wants lawmakers
to preserve the prudent use of OTC derivatives. New regulations should not come
at the cost of proven risk-management tools, he said.
Connelly said that AFP supports eliminating regulatory uncertainty
about which agency regulates which financial instruments. Companies that use
derivatives to manage their risks must have certainty about the legal and
regulatory framework under which they operate, he noted.
Connelly also addressed the proposal to improve oversight and
transparency of the OTC derivatives market by requiring the reporting of all
derivative trades to either a central counterparty (for standardized OTC
derivatives) or to a regulated trade repository (for non-standardized OTC
derivatives). AFP supports the mandatory reporting proposal, he said, but
believes the reporting should be done by the major market participant involved
in the transaction rather than by the corporation that executes derivatives
trades only occasionally. Companies would have to develop an infrastructure to
meet the proposed reporting requirements, he noted, and the added costs would
provide a disincentive for companies to manage their business risks effectively.
Kathleen Moriarty, a partner at Katten Muchin Rosenman,
acknowledged that a merger of the SEC and CFTC is highly unlikely, and so
expressed her support for joint compliance examinations and the joint
registration of investment professionals. In a perfect world, all financial
products would be regulated by a single agency, she said, but that is not likely
to happen given the significant and coordinated changes to both commodities and
securities laws that would be required.
Moriarty believes that the Investment Company Act is the existing
statute best suited to review and regulate pooled vehicles. Although the Act
excludes commodities from the definition of securities that can be held by an
investment company, there is no prohibition against including commodities in the
portfolio of an investment company, she noted.
As a result, Moriarty proposed that the agencies use the existing
exemptive order process under Section 6(c) to create a series of approved
structures for exchange-traded vehicles investing in commodities. If this were
to happen, she said, then all pooled investment vehicles offered to the public,
regardless of their portfolio assets, would be subject to the same regulatory
scheme, would provide comparable disclosure documents, would use advisers with
fiduciary obligations to their clients, and would be subject to review by
regulators familiar with the potential for abuse presented by the portfolio
entities.